» Articles » PMID: 24789704

Protein Tyrosine Kinase 7 Plays a Tumor Suppressor Role by Inhibiting ERK and AKT Phosphorylation in Lung Cancer

Overview
Journal Oncol Rep
Specialty Oncology
Date 2014 May 3
PMID 24789704
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Protein tyrosine kinase 7 (PTK7) is a catalytically inactive receptor tyrosine kinase that is also known as colon carcinoma kinase-4 (CCK-4). Recent reports have shown that PTK7 plays an important role in carcinogenesis, and it is known to be upregulated in gastric, colon and esophageal cancer, as well as in liposarcoma. However, the role of PTK7 in lung cancer has not been investigated. The aim of the present study was to investigate the expression levels and the role of PTK7 in lung cancer. We found that PTK7 expression was downregulated at the mRNA as well as protein levels in human lung squamous cell carcinoma (LSCC). Upon investigation of the functional role of PTK7 in LSCC, we found that overexpression of PTK7 in LSCC cells resulted in inhibition of cell proliferation, invasion and migration. Furthermore, we confirmed that these phenotypic changes are associated with the inactivation of AKT and ERK. Our findings suggest that PTK7 has different oncogenic roles in organs and target tumors.

Citing Articles

PTK7: an underestimated contributor to human cancer.

Jin Z, Guo T, Zhang X, Wang X, Liu Y Front Oncol. 2024; 14:1448695.

PMID: 39474113 PMC: 11518688. DOI: 10.3389/fonc.2024.1448695.


Recent insights into the therapeutic strategies targeting the pseudokinase PTK7 in cancer.

Dessaux C, Ganier L, Guiraud L, Borg J Oncogene. 2024; 43(26):1973-1984.

PMID: 38773263 PMC: 11196218. DOI: 10.1038/s41388-024-03060-x.


Aptamer-Based Probes for Cancer Diagnostics and Treatment.

Hu X, Zhang D, Zeng Z, Huang L, Lin X, Hong S Life (Basel). 2022; 12(11).

PMID: 36431072 PMC: 9695321. DOI: 10.3390/life12111937.


High expression of protein tyrosine kinase 7 in oral squamous cell carcinoma: Clinicopathological correlation and prognosis relevance.

Kimura Y, Yoshizawa K, Hotta-Osada A, Moroi A, Ishii H, Sakurai D Clin Exp Dent Res. 2022; 8(2):506-512.

PMID: 35257502 PMC: 9033537. DOI: 10.1002/cre2.553.


PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells.

Shin W, Park M, Kim J, Oh S, Jang J, Lee H Int J Mol Sci. 2022; 23(4).

PMID: 35216506 PMC: 8876147. DOI: 10.3390/ijms23042391.